| Mangalam Drugs and Organics Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532637 |
NSE Symbol : MANGALAM |
P/E(TTM) : 64.55 |
|
ISIN Demat : INE584F01014 |
Div & Yield% : - |
EPS(TTM) : 2.00 |
|
Book Value(₹) : 89.93 |
Market Cap(₹Cr) : 204.34 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 76.49 | 101.94 | 97.05 | 81.37 | 87.00 | 90.27 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 76.49 | 101.94 | 97.05 | 81.37 | 87.00 | 90.27 |
| Other Operating Income | 0.04 | 0.30 | 0.29 | 0.19 | 0.46 | 0.84 |
| Other Income | 0.02 | 0.05 | 0.00 | 0.03 | 0.02 | 0.29 |
| Total Income | 76.56 | 102.28 | 97.34 | 81.58 | 87.49 | 91.40 |
| Total Expenditure | 68.35 | 90.53 | 90.36 | 79.36 | 90.94 | 90.86 |
| PBIDT | 8.21 | 11.75 | 6.98 | 2.22 | -3.45 | 0.53 |
| Interest | 3.75 | 3.95 | 3.31 | 3.24 | 3.41 | 3.43 |
| PBDT | 4.46 | 7.80 | 3.67 | -1.02 | -6.87 | -2.90 |
| Depreciation | 3.87 | 3.86 | 3.62 | 3.73 | 3.42 | 2.75 |
| Tax | 0.00 | 0.19 | -0.11 | 0.11 | 0.00 | -2.28 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -2.10 | 0.20 | -0.35 | -1.30 | -0.75 | 1.02 |
| Reported Profit After Tax | 2.68 | 3.55 | 0.50 | -3.56 | -9.54 | -4.39 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.68 | 3.55 | 0.50 | -3.56 | -9.54 | -4.39 |
| EPS (Unit Curr.) | 1.70 | 2.24 | 0.32 | -2.25 | -6.02 | -2.77 |
| EPS (Adj) (Unit Curr.) | 1.70 | 2.24 | 0.32 | -2.25 | -6.02 | -2.77 |
| Calculated EPS (Unit Curr.) | 1.70 | 2.24 | 0.32 | -2.25 | -6.02 | -2.77 |
| Calculated EPS (Adj) (Unit Curr.) | 1.70 | 2.24 | 0.32 | -2.25 | -6.02 | -2.77 |
| Calculated EPS (Ann.) (Unit Curr.) | 6.78 | 8.96 | 1.26 | -9.00 | -24.10 | -11.08 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 6.78 | 8.96 | 1.26 | -9.00 | -24.10 | -11.08 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 15.83 | 15.83 | 15.83 | 15.83 | 15.83 | 15.83 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 10.73 | 11.53 | 7.19 | 2.73 | -3.97 | 0.59 |
| PBDTM(%) | 5.83 | 7.65 | 3.78 | -1.25 | -7.90 | -3.21 |
| PATM(%) | 3.50 | 3.48 | 0.52 | -4.38 | -10.97 | -4.86 |